Elanco Animal Health (ELAN) Annual Income Statement (USD)
ELAN Quarterly Financials (USD)
Frequently Asked Questions About Elanco Animal Health (ELAN) Stock
Elanco Animal Health's (ELAN) last reported annual revenue was USD 4.44 Billion.
Elanco Animal Health's (ELAN) annual revenue growth rate based on the revenue reported in the past 5 years is : 7.65%
Elanco Animal Health's(ELAN) is profitable as of its last reported annual financials.
The net profit margin for Elanco Animal Health's(ELAN) from its laster reported year is 7.61%
The return on equity (ROE) for Elanco Animal Health's(ELAN) from its last reported annual financials is : 5.49%
The return on assets (ROA) for Elanco Animal Health's(ELAN) from its last reported annual financials is : 1.19%
The return on invested capital (ROIC) for Elanco Animal Health's(ELAN) from its last reported annual financials is : 0.90%
The Debt to Equity ratio for Elanco Animal Health's(ELAN) from its last reported annual financials is : 70.16%
The dividend yield for Elanco Animal Health's(ELAN) from its laster reported year is 0.00%
Elanco Animal Health's(ELAN) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ELAN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
